RxDoctor Payments Data

Chris Sohn

Podiatrist · Baltimore, MDNPI 1780079764

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (41.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Supreme Orthopedic Systems, LLC at 42.4% of the total. Reporting peaked in 2019 at $1,942 and has fallen 98.9% since, to $21 in 2025.

$2,619in general payments, 2019–2025

Across 40 payments — averaging $65.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supreme Orthopedic Systems, LLC$1K
  • Treace Medical Concepts, Inc.$793
  • Smith+Nephew$164
  • Aroa Biosurgery Incorporated$129
  • Paratek Pharmaceuticals, Inc.$63
  • Sebela Pharmaceuticals Inc.$53
  • plus $307 from 13 others

What the payments were for

  • Travel & lodging$68626%
  • Food & beverage$84432%
  • Education$1,08942%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,619 in reported general payments places this provider in the 75th percentile of 183 podiatrist providers in Maryland.

See all podiatrist providers in Maryland

Medicare billing

Part B allowed, 2024
$148,689
Medicare patients
426
Services billed
1,923

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox156$5,976
Diclofenac Sodium194$4,509
Ammonium Lactate252$3,340
Etodolac50$1,555
Ketoconazole54$818
Gabapentin53$747
Prednisone50$350
Mupirocin31$305
Pregabalin17$299
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$179
Silver Sulfadiazine15$69
Allopurinol11$41

Paid to pharmacies, not to this prescriber.

Other podiatrist in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →